Walleye Trading
KRTX

Walleye Trading’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Walleye Trading’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-700
Closed -$222K – 5581
2023
Q4 		$222K Sell
700
-1,800
-72% -$350K ﹤0.01% 3702
2023
Q3 		$423K Sell
2,500
-3,200
-56% -$602K ﹤0.01% 3084
2023
Q2 		$1.24M Sell
5,700
-3,800
-40% -$814K ﹤0.01% 1998
2023
Q1 		$1.73M Hold
9,500
– – ﹤0.01% 1791
2022
Q4 		$1.87M Sell
9,500
-4,600
-33% -$986K 0.01% 1738
2022
Q3 		$3.17M Buy
14,100
+12,300
+683% +$2.49M 0.01% 1347
2022
Q2 		$228K Sell
1,800
-300
-14% -$34.5K ﹤0.01% 3590
2022
Q1 		$266K Sell
2,100
-3,500
-63% -$394K ﹤0.01% 3547
2021
Q4 		$734K Buy
+5,600
New +$724K ﹤0.01% 2551
2021
Q2 		– Sell
-1,300
Closed -$156K – 5636
2021
Q1 		$156K Sell
1,300
-11,600
-90% -$1.31M ﹤0.01% 3838
2020
Q4 		$1.31M Buy
+12,900
New +$1.2M 0.01% 1749
2020
Q3 		– Sell
-1,700
Closed -$189K – 4736
2020
Q2 		$189K Buy
+1,700
New +$148K ﹤0.01% 3113

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Walleye Trading's KRTX Position: Q1 2024 in Review

Walleye Trading sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,528 shares — an estimated $800K sold.

Walleye Trading first reported a position in KRTX in Q1 2022 and held it in 6 quarters. The position peaked at $1.29M in Q4 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Walleye Trading reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 2,528 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $800K.
  • Walleye Trading first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Walleye Trading's Karuna Therapeutics, Inc. Common Stock position peaked at $1.29M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.